1. Home
  2. NAII vs RNXT Comparison

NAII vs RNXT Comparison

Compare NAII & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Alternatives International Inc.

NAII

Natural Alternatives International Inc.

HOLD

Current Price

$3.55

Market Cap

21.2M

Sector

Health Care

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.86

Market Cap

36.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAII
RNXT
Founded
1980
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
36.4M
IPO Year
1987
2021

Fundamental Metrics

Financial Performance
Metric
NAII
RNXT
Price
$3.55
$0.86
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.75
AVG Volume (30 Days)
17.0K
192.6K
Earning Date
02-13-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$134,440,000.00
$928,000.00
Revenue This Year
N/A
$2,795.35
Revenue Next Year
N/A
$272.69
P/E Ratio
N/A
N/A
Revenue Growth
19.00
N/A
52 Week Low
$2.57
$0.70
52 Week High
$4.40
$1.69

Technical Indicators

Market Signals
Indicator
NAII
RNXT
Relative Strength Index (RSI) 63.57 45.80
Support Level $3.14 $0.79
Resistance Level $3.55 $0.92
Average True Range (ATR) 0.13 0.08
MACD 0.03 -0.00
Stochastic Oscillator 97.87 33.95

Price Performance

Historical Comparison
NAII
RNXT

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: